UniProt ID | RAB1B_HUMAN | |
---|---|---|
UniProt AC | Q9H0U4 | |
Protein Name | Ras-related protein Rab-1B | |
Gene Name | RAB1B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 201 | |
Subcellular Localization |
Cytoplasm . Membrane Lipid-anchor Cytoplasmic side . Preautophagosomal structure membrane Lipid-anchor Cytoplasmic side . Targeted by REP1 to membranes of specific subcellular compartments including endoplasmic reticulum, Golgi apparatus, and |
|
Protein Description | The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. RAB1B regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments. Plays a role in the initial events of the autophagic vacuole development which take place at specialized regions of the endoplasmic reticulum.. | |
Protein Sequence | MNPEYDYLFKLLLIGDSGVGKSCLLLRFADDTYTESYISTIGVDFKIRTIELDGKTIKLQIWDTAGQERFRTITSSYYRGAHGIIVVYDVTDQESYANVKQWLQEIDRYASENVNKLLVGNKSDLTTKKVVDNTTAKEFADSLGIPFLETSAKNATNVEQAFMTMAAEIKKRMGPGAASGGERPNLKIDSTPVKPAGGGCC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNPEYDYL -------CCHHHHHH | 19.94 | - | |
1 | Sulfoxidation | -------MNPEYDYL -------CCHHHHHH | 19.94 | 28183972 | |
5 | Phosphorylation | ---MNPEYDYLFKLL ---CCHHHHHHHHHH | 15.90 | 25159151 | |
7 | Phosphorylation | -MNPEYDYLFKLLLI -CCHHHHHHHHHHHH | 17.09 | 28152594 | |
17 | Phosphorylation | KLLLIGDSGVGKSCL HHHHHCCCCCCCCCE | 30.11 | - | |
21 | Ubiquitination | IGDSGVGKSCLLLRF HCCCCCCCCCEEEEE | 35.27 | 33845483 | |
23 | S-palmitoylation | DSGVGKSCLLLRFAD CCCCCCCCEEEEECC | 3.37 | 29575903 | |
32 | Phosphorylation | LLRFADDTYTESYIS EEEECCCCCCHHHHH | 32.65 | 20068231 | |
33 | Phosphorylation | LRFADDTYTESYIST EEECCCCCCHHHHHH | 18.59 | 28796482 | |
34 | Phosphorylation | RFADDTYTESYISTI EECCCCCCHHHHHHE | 22.13 | 28796482 | |
36 | Phosphorylation | ADDTYTESYISTIGV CCCCCCHHHHHHEEC | 21.70 | 28796482 | |
37 | Phosphorylation | DDTYTESYISTIGVD CCCCCHHHHHHEECC | 7.83 | 28796482 | |
39 | Phosphorylation | TYTESYISTIGVDFK CCCHHHHHHEECCEE | 13.02 | 28796482 | |
40 | Phosphorylation | YTESYISTIGVDFKI CCHHHHHHEECCEEE | 16.52 | 28796482 | |
49 | Phosphorylation | GVDFKIRTIELDGKT ECCEEEEEEEECCEE | 23.44 | 22985185 | |
55 | Malonylation | RTIELDGKTIKLQIW EEEEECCEEEEEEEE | 46.90 | 26320211 | |
55 | Ubiquitination | RTIELDGKTIKLQIW EEEEECCEEEEEEEE | 46.90 | 23000965 | |
56 | Phosphorylation | TIELDGKTIKLQIWD EEEECCEEEEEEEEC | 28.95 | 26307563 | |
58 | Acetylation | ELDGKTIKLQIWDTA EECCEEEEEEEECCC | 39.30 | 66727657 | |
58 | Ubiquitination | ELDGKTIKLQIWDTA EECCEEEEEEEECCC | 39.30 | 23000965 | |
58 | Malonylation | ELDGKTIKLQIWDTA EECCEEEEEEEECCC | 39.30 | 26320211 | |
64 | Phosphorylation | IKLQIWDTAGQERFR EEEEEECCCCHHHHH | 20.07 | 28857561 | |
72 | Phosphorylation | AGQERFRTITSSYYR CCHHHHHHHHHHHHC | 26.37 | 22617229 | |
74 | Phosphorylation | QERFRTITSSYYRGA HHHHHHHHHHHHCCC | 15.82 | 30108239 | |
75 | Phosphorylation | ERFRTITSSYYRGAH HHHHHHHHHHHCCCC | 16.70 | 21130716 | |
76 | Phosphorylation | RFRTITSSYYRGAHG HHHHHHHHHHCCCCE | 19.96 | 28348404 | |
76 | O-(2-cholinephosphoryl)serine | RFRTITSSYYRGAHG HHHHHHHHHHCCCCE | 19.96 | - | |
76 | Other | RFRTITSSYYRGAHG HHHHHHHHHHCCCCE | 19.96 | 22158903 | |
77 | Phosphorylation | FRTITSSYYRGAHGI HHHHHHHHHCCCCEE | 9.28 | 23663014 | |
77 | AMPylation | FRTITSSYYRGAHGI HHHHHHHHHCCCCEE | 9.28 | 20651120 | |
77 | O-AMP-tyrosine | FRTITSSYYRGAHGI HHHHHHHHHCCCCEE | 9.28 | - | |
78 | Phosphorylation | RTITSSYYRGAHGII HHHHHHHHCCCCEEE | 12.43 | 28060719 | |
88 | Phosphorylation | AHGIIVVYDVTDQES CCEEEEEEECCCHHH | 8.19 | 28985074 | |
91 | Phosphorylation | IIVVYDVTDQESYAN EEEEEECCCHHHHHC | 29.12 | - | |
96 | Phosphorylation | DVTDQESYANVKQWL ECCCHHHHHCHHHHH | 11.05 | 18083107 | |
100 | Ubiquitination | QESYANVKQWLQEID HHHHHCHHHHHHHHH | 35.25 | - | |
108 | Methylation | QWLQEIDRYASENVN HHHHHHHHHHCCCHH | 34.28 | - | |
109 | Phosphorylation | WLQEIDRYASENVNK HHHHHHHHHCCCHHH | 15.67 | 26657352 | |
111 | Phosphorylation | QEIDRYASENVNKLL HHHHHHHCCCHHHHH | 22.29 | 25849741 | |
116 | Ubiquitination | YASENVNKLLVGNKS HHCCCHHHHHCCCHH | 38.63 | 23000965 | |
122 | Ubiquitination | NKLLVGNKSDLTTKK HHHHCCCHHHCCCCE | 39.14 | 23000965 | |
128 | Ubiquitination | NKSDLTTKKVVDNTT CHHHCCCCEECCCCC | 38.03 | 33845483 | |
142 | Phosphorylation | TAKEFADSLGIPFLE CHHHHHHHHCCCCCC | 25.68 | 24719451 | |
150 | Phosphorylation | LGIPFLETSAKNATN HCCCCCCCCCCCCCC | 35.81 | 21712546 | |
151 | Phosphorylation | GIPFLETSAKNATNV CCCCCCCCCCCCCCH | 28.06 | 21712546 | |
163 | Sulfoxidation | TNVEQAFMTMAAEIK CCHHHHHHHHHHHHH | 2.54 | 28465586 | |
173 | Sulfoxidation | AAEIKKRMGPGAASG HHHHHHHHCCCCCCC | 11.88 | 21406390 | |
179 | Phosphorylation | RMGPGAASGGERPNL HHCCCCCCCCCCCCC | 46.96 | 25159151 | |
187 | Ubiquitination | GGERPNLKIDSTPVK CCCCCCCEECCCCCC | 51.62 | 33845483 | |
190 | Phosphorylation | RPNLKIDSTPVKPAG CCCCEECCCCCCCCC | 37.78 | 23909892 | |
191 | Phosphorylation | PNLKIDSTPVKPAGG CCCEECCCCCCCCCC | 28.49 | 25159151 | |
200 | Geranylgeranylation | VKPAGGGCC------ CCCCCCCCC------ | 2.55 | 8836150 | |
200 | Geranylgeranylation | VKPAGGGCC------ CCCCCCCCC------ | 2.55 | 8836150 | |
201 | Geranylgeranylation | KPAGGGCC------- CCCCCCCC------- | 7.65 | 8836150 | |
201 | Methylation | KPAGGGCC------- CCCCCCCC------- | 7.65 | - | |
201 | Geranylgeranylation | KPAGGGCC------- CCCCCCCC------- | 7.65 | 8836150 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RAB1B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RAB1B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAB1B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Prenylation | |
Reference | PubMed |
"Membrane targeting of a Rab GTPase that fails to associate with Rabescort protein (REP) or guanine nucleotide dissociation inhibitor(GDI)."; Overmeyer J.H., Wilson A.L., Maltese W.A.; J. Biol. Chem. 276:20379-20386(2001). Cited for: SUBCELLULAR LOCATION, ISOPRENYLATION, INTERACTION WITH GDI1 AND CHM,AND MUTAGENESIS OF TYR-78. | |
"Prenylation of a Rab1B mutant with altered GTPase activity isimpaired in cell-free systems but not in intact mammalian cells."; Wilson A.L., Sheridan K.M., Erdman R.A., Maltese W.A.; Biochem. J. 318:1007-1014(1996). Cited for: ISOPRENYLATION AT CYS-200 AND CYS-201, INTERACTION WITH GDI1, ANDMUTAGENESIS OF GLN-67. |